PDT Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,097
Closed -$365K 1053
2021
Q4
$365K Sell
5,097
-1,025
-17% -$78K 0.03% 623
2021
Q3
$437K Buy
+6,122
New +$483K 0.03% 506
2021
Q2
Sell
-35,108
Closed -$2.65M 911
2021
Q1
$2.65M Sell
35,108
-15
-0% -$1.09K 0.19% 224
2020
Q4
$2.66M Buy
35,123
+24,849
+242% +$1.62M 0.18% 219
2020
Q3
$508K Sell
10,274
-4,129
-29% -$233K 0.03% 443
2020
Q2
$757K Buy
14,403
+3,603
+33% +$171K 0.05% 326
2020
Q1
$380K Buy
10,800
+7,193
+199% +$420K 0.03% 433
2019
Q4
$315K Buy
+3,607
New +$315K 0.02% 527

Other funds holding NGVT

PDT Partners's NGVT Position: Q1 2022 in Review

PDT Partners sold out of Ingevity (NGVT) in Q1 2022, closing a stake of 5,097 shares — an estimated $365K sold.

PDT Partners first reported a position in NGVT in Q4 2019 and held it in 8 quarters. The position peaked at $2.66M in Q4 2020. 274 funds tracked by Wall St. Rank hold NGVT as of Q1 2022.

  • PDT Partners reported no remaining Ingevity position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 5,097 Ingevity shares in Q1 2022, an estimated $365K.
  • PDT Partners first reported a position in Ingevity in Q4 2019 and held it in 8 quarters.
  • PDT Partners's Ingevity position peaked at $2.66M in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Ingevity as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.